A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified Lupus.

Rosalind Ramsey-GoldmanRoberta Vezza AlexanderJohn ConklinCristina ArriensSonali NarainElena M MassarottiDaniel J WallaceChristopher E CollinsAmit SaxenaChaim PuttermanKelley BradyKenneth C KalunianArthur Weinstein

Published in: ACR open rheumatology (2021)

Approximately one-third of patients with pSLE transitioned within the study period. MAP of greater than 0.8 predicted disease evolution into classifiable SLE.

Keyphrases

systemic lupus erythematosus
disease activity
rheumatoid arthritis
single cell
juvenile idiopathic arthritis
high throughput
cell therapy
stem cells